Anti-CD272 / BTLA Reference Antibody (Tifcemalimab), Monoclonal

Produktübersicht

• Artikelname: Anti-CD272 / BTLA Reference Antibody (Tifcemalimab), Monoclonal
• Artikelnummer: SYB-CHB332
• Hersteller Artikelnummer: CHB332
• Alternativnummer: SYB-CHB332-100UG, SYB-CHB332-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics

Produktbeschreibung

Anti-CD272 / BTLA Reference Antibody (Tifcemalimab)(CHB332) is expressed from CHO. The heavy chain type is IgG4SP, and the light chain type is kappa. It has a predicted MW of 146 kDa.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1mg/ml
• UniProt: Q7Z6A9
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: CD272 / BTLA